Pulse Biosciences (PLSE) Finished Goods (2021 - 2022)

Pulse Biosciences' (PLSE) quarterly Finished Goods came in at $750000.0 in Q3 2022, down 55.91% year-on-year from $1.7 million in Q3 2021, and down 71.0% quarter-over-quarter from $2.6 million in Q2 2022.

Pulse Biosciences (PLSE) Finished Goods (2021 - 2022) Analysis & Trends

Pulse Biosciences' Finished Goods history runs 2 years deep, the most recent figure standing at $750000.0 for Q3 2022.

  • On a quarterly basis, Finished Goods fell 55.91% year-over-year to $750000.0 in Q3 2022; TTM through Sep 2022 was $750000.0, a 55.91% decrease from a year earlier, with the FY2021 full-year figure at $2.4 million, changed N/A from the prior year.
  • Finished Goods slipped to $750000.0 in Q3 2022 per PLSE's latest filing, from $2.6 million in the prior quarter.
  • Across five years, Finished Goods topped out at $2.7 million in Q1 2022 and bottomed at $750000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Pulse Biosciences 2.09 Bn 2.01 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2022 750,000.00
Jun 30, 2022 2.59 Mn
Mar 31, 2022 2.74 Mn
Dec 31, 2021 2.44 Mn
Sep 30, 2021 1.70 Mn